Doctor profile · Federal record
Dr. Vanita Srivastava, D.O.
Dermatology Physician (CMS: Dermatology) · Far Rockaway, NY
- NPI 1891119285
- Accepts Medicare
- MIPS 79.0 / 100 · 2023
- 13 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
327 Beach 19Th St
Far Rockaway, NY 116914423
(718) 869-7108
Credentials & registration
- NPI registered
- February 2014 — 12 yrs on file
- Profile last updated
- April 17, 2017
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #280641
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891119285. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,358
Distinct HCPCS
10
Medicare allowed
$278,894
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 950 | 664 | $105 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 713 | 184 | $8 | |
11102 |
Biopsy of related skin growth, first growth | 397 | 334 | $111 | |
17000 |
Destruction of precancer skin growth, 1 growth | 394 | 288 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 282 | 282 | $131 | |
17110 |
Destruction of skin growth, 1-14 growths | 261 | 198 | $134 | |
11103 |
Biopsy of related skin growth, each additional growth | 148 | 96 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 58 | 54 | $147 | |
10040 |
Acne surgery | 27 | 26 | $140 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | 16 | $1 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 197. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$1,944
Transactions
104
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 13 | $428.74 | |
| LEO Pharma Inc. | 20 | $350.12 | |
| Novartis Pharmaceuticals Corporation | 26 | $322.35 | |
| Dermavant Sciences, Inc. | 21 | $320.65 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $112.57 | |
| ABBVIE INC. | 4 | $102.72 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $79.34 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $62.53 | |
| Lilly USA, LLC | 2 | $43.88 | |
| Galderma Laboratories, L.P. | 2 | $39.27 | |
| GENZYME CORPORATION | 2 | $36.04 | |
| Incyte Corporation | 1 | $23.26 | |
| PFIZER INC. | 1 | $22.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
817
Patients
562
Total drug cost
$128,022
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 117 | 63 | $2,189 |
| Clobetasol Propionate | Generic | 103 | 64 | $6,533 |
| Triamcinolone Acetonide | Generic | 102 | 86 | $1,189 |
| Doxycycline Hyclate | Generic | 72 | 53 | $2,892 |
| Mupirocin | Generic | 65 | 56 | $620 |
| Metronidazole | Generic | 56 | 28 | $3,730 |
| Fluorouracil | Generic | 54 | 52 | $4,148 |
| Hydrocortisone | Generic | 44 | 43 | $206 |
| Prednisone | Generic | 33 | 29 | $114 |
| Finasteride | Generic | 32 | 14 | $215 |
Frequently asked questions
What is Dr. Vanita Srivastava's medical specialty?
Dr. Vanita Srivastava practices Dermatology Physician in Far Rockaway, NY.
Where does Dr. Vanita Srivastava practice?
Dr. Vanita Srivastava practices at 327 Beach 19Th St, Far Rockaway, NY 116914423. Office phone: 7188697108.
What is Dr. Vanita Srivastava's NPI?
Dr. Vanita Srivastava's National Provider Identifier (NPI) is 1891119285, issued by NPPES.
Does Dr. Vanita Srivastava accept Medicare assignment?
Yes. Dr. Vanita Srivastava accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vanita Srivastava commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.